Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOPAGATE sulpiride placebo crossover pharmaco-fMRI study in healthy adults
NL-OMON57489Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sulpiride (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Laminar fMRI BOLD signal and Behavioral performance on cognitive tasks. Started May 2025; status: completed.
02
Drugs
sulpiride
Beyond the preview
Go deeper on NL-OMON57489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57489.